The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi as the first needle-free treatment for severe low blood sugar levels (hypoglycaemia) in diabetics in the EU ...

本仓库用来存放 B 站课程 《现代 C++ 模板教程 2024》的教案、代码，和作业。 任何组织和个人遵守 CC BY-NC-ND 4.0 ...

Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease congenital hyperinsulinism (CHI) to the US market. For the second time in ...